| Filed On | Filing |
|---|---|
| 15 Oct 2026 |
8-K: Entry into a Material Definitive Agreement
CERTAIN INFORMATION CONTAINED IN THIS AGREEMENT HAS BEEN OMITTED BY MEANS OF REDACTING A PORTION OF THE TEXT AND REPLACING IT WITH [***] BECAUSE SUCH INFORMATION IS BOTH (I) NOT MATERIAL AND (II) THE TYPE THAT THE REGISTRANT TREATS AS PR... |
| 02 Oct 2026 |
8-K: Other Events
On October 1, 2026, OPKO Health, Inc. (the “Company”) determined that its 3.75% Convertible Senior Notes due 2029 (the “Notes”), of which approximately $121 million is outstanding, are convertible by holders of such Notes through Decembe... |
| 28 Aug 2026 | 10-Q/A |
| 28 Aug 2026 | 10-Q/A |
| 14 Aug 2026 | 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation |
| 07 Aug 2026 | SCHEDULE 13D |
| 28 Jul 2026 |
Form 4: Logal Adam, Sr. Vice President, CFO
Gave up 53,266 shares to cover exercise price or tax ($65K) |
| 28 Jul 2026 |
Form 4: Rubin Steven D, Director
Gave up 53,266 shares to cover exercise price or tax ($65K) |
| 27 Jul 2026 | 10-Q |
| 27 Jul 2026 | 8-K: Results of Operations and Financial Condition |
| 01 Jul 2026 | SCHEDULE 13D/A |
| 22 Jun 2026 |
Form 4: Lachman Prem A, Director
Granted 30,000 Stock Option (Right to Buy) |
| 22 Jun 2026 |
Form 4: Medel Roger Md, Director
Granted 30,000 Stock Option (Right to Buy) |
| 22 Jun 2026 |
Form 4: Paganelli John A, Director
Granted 30,000 Stock Option (Right to Buy) |
| 22 Jun 2026 |
Form 4: Pfenniger Richard C Jr, Director
Granted 60,000 Stock Option (Right to Buy) |
| 22 Jun 2026 |
Form 4: Uppaluri Subbarao V, Director
Granted 80,000 Stock Option (Right to Buy) |
| 22 Jun 2026 |
Form 4: Yu Alice Lin-Tsing, Director
Granted 30,000 Stock Option (Right to Buy) |
| 18 Jun 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 15 May 2026 | DEFA14A |
| 30 Apr 2026 | ARS |
Loading...
